LASANTH

Live / Registered — Registered (as of 31 Dec 2024)

What this means for you

Registered since 31 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90236132
Registration number
7634013
Mark type
Stylized text
Filed
05 Oct 2020
Published for opposition
06 Apr 2021
Registered
31 Dec 2024
Attorney of record
Brian J. Focarino

Goods and services

  • Class 035 — Advertising and business services: Business consulting services in the field of regulatory compliance; business development services; business strategy development services; business consulting and management in the field of clinical trials, namely, regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing applications for medical technologies, medications, pharmaceutical, biopharmaceuticals, and biotechnology with governmental regulatory bodies around the world; regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical technologies, medications, pharmaceutical, biopharmaceuticals, and biotechnology; providing information online regarding regulatory submission management; business management consulting, strategic planning and business advisory services provided to medical, medical technology, pharmaceutical, biopharmaceutical, and biotechnology companies, and government agencies, educational and research institutions, in the fields of biologics and pharmaceuticals; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug approval; regulatory submission management, namely, assisting others in preparing applications for new drugs with governmental regulatory bodies; business consulting services in the field of biologics and pharmaceuticals
  • Class 042 — Scientific and technological services: Product research and development for others in the fields of biologics and pharmaceuticals; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biologics and pharmaceuticals; scientific consulting and research services relating to the field of pharmaceuticals and life sciences, namely, biology, and medicine; consulting services in the fields of biotechnology and pharmaceuticals, namely, design, development, technical verification and technical validation of manufacturing and filling processes, drug formulations, testing protocols and analytical methods; scientific and technological services, namely, scientific research, analysis, testing, and related scientific studies in the field of chemistry and molecular biology, namely, biologics and protein detection, characterization, analysis and testing
  • Class 045 — Legal and security services: Regulatory compliance consulting services, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules in the fields of medical technologies, medications, biopharmaceuticals, and biotechnology; providing technical regulatory affair consulting services directed to medical, medical technology, biopharmaceutical, and biotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical technologies, medications, biopharmaceuticals, and biotechnology; and regulatory compliance consulting in the fields of biologics and pharmaceuticals

Owner

Prosecution history

  • 31 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 31 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
  • 06 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 06 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 05 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 05 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 05 Nov 2024 — ASSIGNED TO LIE
  • 12 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 17 Jul 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 17 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 17 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 17 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 29 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 29 May 2024 — NON-FINAL ACTION E-MAILED
  • 29 May 2024 — SU - NON-FINAL ACTION - WRITTEN

View this trademark record on Marksy